Centogene N.V. (CNTG)
NASDAQ: CNTG · IEX Real-Time Price · USD
0.520
-0.001 (-0.10%)
At close: Jul 19, 2024, 4:00 PM
0.530
+0.010 (1.92%)
Pre-market: Jul 22, 2024, 6:50 AM EDT

Centogene Revenue

In the year 2023, Centogene had annual revenue of $53.93M with 6.78% growth.

Revenue (ttm)
$53.93M
Revenue Growth
-189.13%
P/S Ratio
0.28
Revenue / Employee
$140,440
Employees
384
Market Cap
15.07M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202353.93M3.43M6.78%
Dec 31, 202250.50M2.51M5.23%
Dec 31, 202147.99M1.10M2.34%
Dec 31, 202046.89M-7.92M-14.44%
Dec 31, 201954.81M8.28M17.80%
Dec 31, 201846.53M8.50M22.35%
Dec 31, 201738.03M8.91M30.60%
Dec 31, 201629.12M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
China Jo-Jo Drugstores 154.66M
Star Equity Holdings 42.56M
BIMI International Medical 5.85M
Immuron 2.43M
Talis Biomedical 989.00K
Talphera 651.00K
Revenue Rankings